
RiverVest sells portfolio company Lumena to Shire for USD260 million
RiverVest Venture Partners has sold portfolio company Lumena Pharmaceuticals to Dublin-based Shire Plc in a transaction with an upfront payment of USD260 million in cash. The deal also includes a payment for net cash at closing, and near-term contingent milestone payments related to ongoing clinical trials. In the three



